Ontology highlight
ABSTRACT:
INSTRUMENT(S): Synapt MS
ORGANISM(S): Homo Sapiens (human)
SUBMITTER: Antonio Calabrese
LAB HEAD: Antonio Calabrese
PROVIDER: PXD037151 | Pride | 2023-11-16
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
NicA2_NEW.DnX | Other | |||
fbsaca_220908_NicA2_01.raw.zip | Raw | |||
fbsaca_220908_NicA2_03.raw.zip | Raw | |||
fbsaca_220908_NicA2_05.raw.zip | Raw | |||
fbsaca_220908_NicA2_07.raw.zip | Raw |
Items per page: 1 - 5 of 49 |
Nature chemical biology 20230928 11
The flavoenzyme nicotine oxidoreductase (NicA2) is a promising injectable treatment to aid in the cessation of smoking, a behavior responsible for one in ten deaths worldwide. NicA2 acts by degrading nicotine in the bloodstream before it reaches the brain. Clinical use of NicA2 is limited by its poor catalytic activity in the absence of its natural electron acceptor CycN. Without CycN, NicA2 is instead oxidized slowly by dioxygen (O<sub>2</sub>), necessitating unfeasibly large doses in a therape ...[more]